These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37486310)

  • 1. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
    Visos-Varela I; Zapata-Cachafeiro M; Pintos-Rodríguez S; Bugarín-González R; González-Barcala FJ; Herdeiro MT; Piñeiro-Lamas M; Figueiras A; Salgado-Barreira Á
    J Med Virol; 2023 Jul; 95(7):e28971. PubMed ID: 37486310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
    García-Álvarez RM; Zapata-Cachafeiro M; Visos-Varela I; Rodríguez-Fernández A; Pintos-Rodríguez S; Piñeiro-Lamas M; Herdeiro TM; Figueiras A; Salgado-Barreira A;
    Inflammopharmacology; 2024 Jun; 32(3):1805-1815. PubMed ID: 38619761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.
    Pintos-Rodríguez S; Visos-Varela I; Rodríguez-Fernández A; Zapata-Cachafeiro M; Piñeiro-Lamas M; Herdeiro MT; García-Álvarez RM; Figueiras A; Salgado-Barreira Á
    Int J Neuropsychopharmacol; 2024 Apr; 27(4):. PubMed ID: 38600711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin.
    Ouellette DR; Moscoso EE; Corrales JP; Peters M
    Ann Intensive Care; 2015; 5():9. PubMed ID: 25992302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
    BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization.
    Salgado-Barreira A; Seijas-Amigo J; Rodriguez-Mañero M; Piñeiro-Lamas M; Eiras S; Cordero A; Gonzalez-Juanatey JR; Figueiras A
    J Antimicrob Chemother; 2023 Sep; 78(9):2335-2342. PubMed ID: 37549309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.
    Sperry MM; Oskotsky TT; Marić I; Kaushal S; Takeda T; Horvath V; Powers RK; Rodas M; Furlong B; Soong M; Prabhala P; Goyal G; Carlson KE; Wong RJ; Kosti I; Le BL; Logue J; Hammond H; Frieman M; Stevenson DK; Ingber DE; Sirota M; Novak R
    PLoS Comput Biol; 2023 May; 19(5):e1011050. PubMed ID: 37146076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
    Aggarwal NR; Beaty LE; Bennett TD; Carlson NE; Davis CB; Kwan BM; Mayer DA; Ong TC; Russell S; Steele J; Wogu AF; Wynia MK; Zane RD; Ginde AA
    J Infect Dis; 2022 Dec; 226(12):2129-2136. PubMed ID: 35576581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID-19 patients.
    Andrews L; Goldin L; Shen Y; Korwek K; Kleja K; Poland RE; Guy J; Sands KE; Perlin JB
    J Hosp Med; 2022 Mar; 17(3):169-175. PubMed ID: 35504528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.
    Lohia P; Kapur S; Benjaram S; Cantor Z; Mahabadi N; Mir T; Badr MS
    Cardiovasc Diabetol; 2021 Jul; 20(1):140. PubMed ID: 34246277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and fall-related hospitalizations among residents of long-term care facilities: A case-control study.
    Wang KN; Bell JS; Tan EC; Gilmartin-Thomas JF; Dooley MJ; Ilomäki J
    J Clin Lipidol; 2020; 14(4):507-514. PubMed ID: 32571729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use associated with a reduced risk of pneumonia requiring hospitalization in patients with myocardial infarction: a nested case-control study.
    Lin CF; Chang YH; Liu JC; Chuang MT; Chien LN
    BMC Cardiovasc Disord; 2016 Jan; 16():24. PubMed ID: 26823081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.
    Davoudi A; Ahmadi M; Sharifi A; Hassantabar R; Najafi N; Tayebi A; Kasgari HA; Ahmadi F; Rabiee M
    Biomed Res Int; 2021; 2021():9995073. PubMed ID: 34250095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-Based Cohort Study on the Drug-Specific Effect of Statins on Sepsis Outcome.
    Lee CC; Lee MG; Hsu TC; Porta L; Chang SS; Yo CH; Tsai KC; Lee M
    Chest; 2018 Apr; 153(4):805-815. PubMed ID: 28962887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
    Rublee DA; Burke JP
    Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
    Milner E; Ainsworth M; Gleaton M; Bookstaver D
    J Clin Pharm Ther; 2022 May; 47(5):668-675. PubMed ID: 35032137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.